Clinical TrialsSearch results
Number of results: 718
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2007-09-01
Other
- A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)
- Symptomatic uterine leimoyoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase I/II study of weekly paclitaxel therapy for metastatic gastric cancer (Step 2)
- Fluoropyrimidine failure metastatic gastric cancer
- Hiroshima Cancer Therapy Development Organization (HiCTDO)
- 2005-10-01
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- A phase II study of 2nd-line FOLFIRI+aflibercept in patients with colorectal cancer resistant to anti-EGFR chemotherapy (HGCSG1801)
- colorectal cancer
- Komatsu Yoshito
- 2019-11-19
Other
- A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- West Japan Oncology Group
- 2008-09-12
Other
- A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
- advanced gastric cancer
- Dept. of Internal Medicine(4)
- 2007-08-15
Recruiting
- A phase II study of eribulin monotherapy for advanced extramammary Paget's disease
- extramammary Paget's disease
- Yanagi Teruki
- 2022-10-28
Other
- A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus
- Leiomyosarcoma of Uterus
- Japanese Gynecologic Oncology Group
- 2006-07-13